SEC Comment Letter 0000000000-23-012813 to Z Squared Inc. (COEP)
Z Squared Inc.
Date: Nov. 22, 2023 · CIK: 0001759186 · Accession: 0000000000-23-012813
AI Filing Summary & Sentiment
File numbers found in text: 333-275558
Letter
United States securities and exchange commission logo November 22, 2023 David Mehalick Chief Executive Officer Coeptis Therapeutics Holdings, Inc. 105 Bradford Road , Suite 420 Wexford, PA 15090 Re:Coeptis Therapeutics Holdings, Inc. Registration Statement on Form S-1 Filed November 15, 2023 File No. 333-275558 Dear David Mehalick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Denis Dufresne
Show Raw Text
United States securities and exchange commission logo
November 22, 2023
David Mehalick
Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road , Suite 420
Wexford, PA 15090
Re:Coeptis Therapeutics Holdings, Inc.
Registration Statement on Form S-1
Filed November 15, 2023
File No. 333-275558
Dear David Mehalick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Denis Dufresne